Jazz Pharmaceuticals plc Common Stock (Ireland) Earnings Dividend

Jazz Pharmaceuticals plc Common Stock (Ireland)’s revenue jumped 19.05% since last year same period to $1068.9Mn in the Q1 2026. On a quarterly growth basis, Jazz Pharmaceuticals plc Common Stock (Ireland) has generated -10.77% fall in its revenue since last 3-months.

Jazz Pharmaceuticals plc Common Stock (Ireland)’s net profit jumped 416.72% since last year same period to $293.1Mn in the Q1 2026. On a quarterly growth basis, Jazz Pharmaceuticals plc Common Stock (Ireland) has generated 44.06% jump in its net profits since last 3-months.

Jazz Pharmaceuticals plc Common Stock (Ireland)’s net profit margin jumped 366.04% since last year same period to 27.42% in the Q1 2026. On a quarterly growth basis, Jazz Pharmaceuticals plc Common Stock (Ireland) has generated 61.45% jump in its net profit margins since last 3-months.

Jazz Pharmaceuticals plc Common Stock (Ireland)’s price-to-earnings ratio after this Q1 2026 earnings stands at 1918.75.

Jazz Pharmaceuticals plc Common Stock (Ireland)’s earning per share (EPS) estimates for the current quarter stand at 5.06 - a 8.58% jump from last quarter’s estimates.

Jazz Pharmaceuticals plc Common Stock (Ireland)’s earning per share (EPS) estimates for the current year stand at 5.06.

Jazz Pharmaceuticals plc Common Stock (Ireland)’s earning per share (EPS) jumped 277.38% since last year same period to 6.34 in the Q1 2026. This indicates that the Jazz Pharmaceuticals plc Common Stock (Ireland) has generated 277.38% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Jazz Pharmaceuticals plc Common Stock (Ireland)’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Jazz Pharmaceuticals plc Common Stock (Ireland)’s return on equity (ROE) stands at 0.01.